Anti-Human CXCL13 Therapeutic Antibody (3C9)
This antibody that specifically binds to CXCL13 may be used for treating autoimmune or inflammatory diseases, cancers, mucosa-associated lymphoid tissue (MALT) lymphomas, gastric or duodenal ulcers, as well as inhibiting gastric lymphoid follicles.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-103MZ |
| Pricing | Inquiry |
| Applications | Enzyme-linked Immunosorbent Assay |
| Host | Mouse |
| Target | Homeostatic B Cell-Attracting chemokine 1 (BCA-1, also known as CXCL13, ANGIE, BLC, BLR1L, ANGIE2, or Scybl3) |
| Species Reactivity | Mouse, Cynomolgus monkey |